respiratory
Risk factors

World first trial will address early COPD in smokers


Young smokers aged 25-45  have been invited to take part in a world first trial that will assess whether two long acting bronchodilators can slow down lung function decline in smokers. The George Institute, in collaboration with the Woolcock Institute of Medical Research, Concord, Campbelltown and Royal North Shore Hospitals, is seeking to enrol 320 ...

Already a member?

Enter your email to keep reading.


OR